Published Date:2021-09-04 Original Link:https://www.onenessbio.com/en/news_detail56_2.htm No 2 Date of announcement 2021/09/04 Time of announcement 12:23:26 Subject The data of the Phase 3 international multicenter clinical trial and the mechanism of action of Fespixon (ON101) have been published by JAMA Network Open To which item it meets paragraph 53 Date of events 2021/09/03 Statement ...Read More
Published Date:2021-09-04 Original Link:https://www.onenessbio.com/en/news_detail55_2.htm No 1 Date of announcement 2021/09/04 Time of announcement 00:51:50 Subject Oneness decided not to proceed with FB704A phase 2 IND application in patients with severe COVID-19 based on strategic consideration To which item it meets paragraph 10 Date of events 2021/09/03 Statement 1.Product:FB704A 2.Mass production date:NA 3.Effect on...Read More
Published Date:2021-09-02 Original Link:https://www.onenessbio.com/en/news_detail54_2.htm No 1 Date of announcement 2021/09/02 Time of announcement 17:24:08 Subject Oneness Biotech Co., LTD receives a Japanese patent on OB318, a new drug in development for liver cancer. To which item it meets paragraph 53 Date of events 2021/09/02 Statement 1.Date of occurrence of the event:2021/09/02 2.Company name:ONENESS...Read More
Published Date:2021-08-10 Original Link:https://www.onenessbio.com/en/news_detail53_2.htm No 1 Date of announcement 2021/08/09 Time of announcement 17:42:02 Subject Oneness Biotech Co., LTD receives a Chinese patent on OB318, a new drug in development for liver cancer. To which item it meets paragraph 53 Date of events 2021/08/09 Statement 1.Date of occurrence of the event:2021/08/09 2.Company name:ONENESS...Read More
Published Date:2021-08-06 Original Link:https://www.onenessbio.com/en/news_detail52_3.htm No 3 Date of announcement 2021/08/06 Time of announcement 19:03:38 Subject A Chinese patent on the producing of recombinant glycoproteins with modified glycosylation was granted. To which item it meets paragraph 53 Date of events 2021/08/06 Statement 1.Date of occurrence of the event:2021/08/06 2.Company name:ONENESS BIOTECH CO., LTD. 3.Relationship to...Read More
Published Date:2021-07-21 Original Link:https://www.onenessbio.com/en/news_detail51_3.htm No 1 Date of announcement 2021/07/21 Time of announcement 18:51:43 Subject Oneness Biotech Co., LTD. receives a Russian patent titled”TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code:ON101). To which item it meets paragraph 53 Date of events 2021/07/21 Statement 1.Date of occurrence of the event:2021/07/21 2.Company...Read More
